233 related articles for article (PubMed ID: 28333207)
1. Endometrial thickness in women undergoing IUI with ovarian stimulation. How thick is too thin? A systematic review and meta-analysis.
Weiss NS; van Vliet MN; Limpens J; Hompes PGA; Lambalk CB; Mochtar MH; van der Veen F; Mol BWJ; van Wely M
Hum Reprod; 2017 May; 32(5):1009-1018. PubMed ID: 28333207
[TBL] [Abstract][Full Text] [Related]
2. Endometrial thickness as a biomarker for ongoing pregnancy in IUI for unexplained subfertility: a secondary analysis.
Danhof NA; van Eekelen R; Repping S; Mol BWJ; van der Veen F; van Wely M; Mochtar MH;
Hum Reprod Open; 2020; 2020(1):hoz024. PubMed ID: 31934648
[TBL] [Abstract][Full Text] [Related]
3. IUI for unexplained infertility-a network meta-analysis.
Danhof NA; Wang R; van Wely M; van der Veen F; Mol BWJ; Mochtar MH
Hum Reprod Update; 2020 Jan; 26(1):1-15. PubMed ID: 31803930
[TBL] [Abstract][Full Text] [Related]
4. Ovarian stimulation strategies for intrauterine insemination in couples with unexplained infertility: a systematic review and individual participant data meta-analysis.
Wessel JA; Danhof NA; van Eekelen R; Diamond MP; Legro RS; Peeraer K; D'Hooghe TM; Erdem M; Dankert T; Cohlen BJ; Thyagaraju C; Mol BWJ; Showell M; van Wely M; Mochtar MH; Wang R
Hum Reprod Update; 2022 Aug; 28(5):733-746. PubMed ID: 35587030
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility.
van Eekelen R; Wang R; Danhof NA; Mol F; Mochtar M; Mol BW; van Wely M
Hum Reprod; 2021 Apr; 36(5):1288-1295. PubMed ID: 33615360
[TBL] [Abstract][Full Text] [Related]
6. Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis.
Bordewijk EM; Weiss NS; Nahuis MJ; Bayram N; van Hooff MHA; Boks DES; Perquin DAM; Janssen CAH; van Golde RJT; Lambalk CB; Goddijn M; Hompes PG; van der Veen F; Mol BWJ; van Wely M;
Hum Reprod; 2019 Feb; 34(2):276-284. PubMed ID: 30576539
[TBL] [Abstract][Full Text] [Related]
7. Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis.
Gadalla MA; Huang S; Wang R; Norman RJ; Abdullah SA; El Saman AM; Ismail AM; van Wely M; Mol BWJ
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):64-76. PubMed ID: 29055102
[TBL] [Abstract][Full Text] [Related]
8. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM
Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569
[TBL] [Abstract][Full Text] [Related]
9. Gonadotrophins or clomiphene citrate in women with normogonadotropic anovulation and CC failure: does the endometrium matter?
Bordewijk EM; Weiss NS; Nahuis MJ; Kwee J; Lambeek AF; van Unnik GA; Vrouenraets FPJ; Cohlen BJ; van de Laar-van Asseldonk TAM; Lambalk CB; Goddijn M; Hompes PG; van der Veen F; Mol BWJ; van Wely M;
Hum Reprod; 2020 Jun; 35(6):1319-1324. PubMed ID: 32585686
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial.
Bordewijk EM; Jannink TI; Weiss NS; de Vries T; Nahuis M; Hoek A; Goddijn M; Mol BW; van Wely M;
Hum Reprod; 2023 Mar; 38(3):421-429. PubMed ID: 36622200
[TBL] [Abstract][Full Text] [Related]
11. Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial.
Wessel JA; Mochtar MH; Besselink DE; Betjes H; de Bruin JP; Cantineau AEP; Groenewoud ER; Hooker AB; Lambalk CB; Kwee J; Kaaijk EM; Louwé LA; Maas JWM; Mol BWJ; van Rumste MME; Traas MAF; Goddijn M; van Wely M; Mol F
Hum Reprod; 2022 Nov; 37(12):2808-2816. PubMed ID: 36331493
[TBL] [Abstract][Full Text] [Related]
12. Endometrial thickness after ovarian stimulation with gonadotropin, clomiphene, or letrozole for unexplained infertility, and association with treatment outcomes.
Quaas AM; Gavrizi SZ; Peck JD; Diamond MP; Legro RS; Robinson RD; Casson P; Christman GM; Zhang H; Hansen KR;
Fertil Steril; 2021 Jan; 115(1):213-220. PubMed ID: 32972733
[TBL] [Abstract][Full Text] [Related]
13. Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial.
Danhof NA; van Wely M; Repping S; Koks C; Verhoeve HR; de Bruin JP; Verberg MFG; van Hooff MHA; Cohlen BJ; van Heteren CF; Fleischer K; Gianotten J; van Disseldorp J; Visser J; Broekmans FJM; Mol BWJ; van der Veen F; Mochtar MH;
Hum Reprod; 2018 Oct; 33(10):1866-1874. PubMed ID: 30137325
[TBL] [Abstract][Full Text] [Related]
14. Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility.
Cantineau AE; Cohlen BJ; Heineman MJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD005356. PubMed ID: 17443584
[TBL] [Abstract][Full Text] [Related]
15. The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial.
Nahuis MJ; Weiss NS; van der Veen F; Mol BW; Hompes PG; Oosterhuis J; Lambalk NB; Smeenk JM; Koks CA; van Golde RJ; Laven JS; Cohlen BJ; Fleischer K; Goverde AJ; Gerards MH; Klijn NF; Nekrui LC; van Rooij IA; Hoozemans DA; van Wely M
BMC Womens Health; 2013 Oct; 13():42. PubMed ID: 24160333
[TBL] [Abstract][Full Text] [Related]
16. IVF or IUI as first-line treatment in unexplained subfertility: the conundrum of treatment selection markers.
Tjon-Kon-Fat RI; Tajik P; Zafarmand MH; Bensdorp AJ; Bossuyt PMM; Oosterhuis GJE; van Golde R; Repping S; Lambers MDA; Slappendel E; Perquin D; Pelinck MJ; Gianotten J; Maas JWM; Eijkemans MJC; van der Veen F; Mol BW; van Wely M;
Hum Reprod; 2017 May; 32(5):1028-1032. PubMed ID: 28333222
[TBL] [Abstract][Full Text] [Related]
17. Ovarian stimulation in infertile women treated with the use of intrauterine insemination: a cohort study from China.
Huang S; Wang R; Li R; Wang H; Qiao J; Mol BWJ
Fertil Steril; 2018 May; 109(5):872-878. PubMed ID: 29778386
[TBL] [Abstract][Full Text] [Related]
18. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
[TBL] [Abstract][Full Text] [Related]
19. Is IUI with ovarian stimulation effective in couples with unexplained subfertility?
van Eekelen R; van Geloven N; van Wely M; McLernon DJ; Mol F; Custers IM; Steures P; Bhattacharya S; Mol BW; van der Veen F; Eijkemans MJ
Hum Reprod; 2019 Jan; 34(1):84-91. PubMed ID: 30395266
[TBL] [Abstract][Full Text] [Related]
20. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
